Shorter radiation after breast reconstruction proves safe and effective

eurekalert.org —

A clinical trial found that a three-week course of radiation after mastectomy and breast reconstruction is as safe and effective as the standard five-week treatment, potentially easing travel and time burdens for patients. The RT CHARM trial, led by Huntsman Cancer Institute physician Matthew Poppe and published in the Journal of Clinical Oncology, enrolled 898 patients across 209 sites in the US and Canada. Results showed the shorter 16-session course did not increase cancer recurrence or reconstruction complications. The findings are significant for patients traveling long distances for care, as nearly a third of Huntsman patients travel over 150 miles. Poppe noted many patients previously declined radiation due to the five-week commitment, and the shorter option improves accessibility.


With a significance score of 5, this news ranks in the top 1.7% of today's 29807 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: